Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Future Health Institute is a Swiss-based biotechnology and healthcare company specializing in longevity and regenerative medicine. The institute provides personalized health optimization through advanced diagnostics, including epigenetic testing and biomarker analysis, alongside therapeutic interventions such as mesenchymal stem cell therapies. Based in Zurich, the company integrates clinical practice with research to develop protocols aimed at extending human healthspan and treating age-related degeneration. Their services cater to a high-end market seeking biohacking and preventative medical solutions. The institute operates at the intersection of cutting-edge gerontology and clinical application, offering a comprehensive approach to biological age reversal.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Future Health Institute.